期刊文献+

不同抗凝剂种类、操作和保存方法对血浆微粒检测影响 被引量:7

Influences of different anticoagulants,preparation and preservation methods on detection of circulating microparticles
原文传递
导出
摘要 目的探讨不同抗凝剂种类、标本处理方式、保存温度及时间对血浆微粒(MPs)检测效果的影响。方法采集2013年8月—2014年5月在苏州大学附属第二医院住院治疗的40例系统性红斑狼疮患者、41例类风湿性关节炎患者和52名健康对照者血浆标本;采用流式细胞术(FCM)计数不同抗凝剂[枸橼酸盐、乙二胺四乙酸二钾(EDTA-K2)、肝素]、标本处理方式[洗涤贫血小板血浆(PPP)和直接PPP]、保存温度(-4、-20、-80℃)及时间(1、3、7、10、14 d)血浆中MPs的含量。结果采用枸橼酸盐、EDTA-K2、肝素抗凝剂和无抗凝剂血浆中MPs含量分别为(1 527.0±620.4)、(981.4±247.9)、(877.7±176.2)和(480.8±112.2)μL,差异有统计学意义(F=9.11,P<0.01);系统性红斑狼疮患者、类风湿性关节炎患者和健康对照者直接PPP MPs含量分别为(1 972.4±2 850.7)、(3 347.8±3431.5)和(2 157.7±1 901.1)μL,均高于洗涤PPP的(1 406.4±2 205.7)、(2 375.6±2 500.2)和(1 502.8±1 337.1)μL(均P<0.01);与新鲜血浆标本MPs含量比较,-4℃、-20℃下血浆标本保存1、3、7、10 d和-80℃下血浆标本保存3、7、10 d MPs含量均下降,差异均有统计学意义(P<0.05);而在3个温度下保存14 d MPs含量开始升高,与新鲜血浆标本MPs含量比较,差异均无统计学意义(P>0.05);分别对3个温度下保存1、3、7、10、14 d血浆标本MPs含量比较,差异均无统计学意义(P>0.05)。结论检测血浆MPs含量时宜选用新鲜EDTA-K2抗凝标本且无需多次离心洗涤,短期内标本保存在-4℃、-20℃、-80℃下均可。 Objective To investigate effects of anticoagulant,sample preparation,storage temperature and time on detection of circulating microparticles( MPs). Methods The blood samples of 40 systemic lupus erythematosus and 41 rheumatoid arthritis inpatients from the Second Affiliated Hospital of SoochowUniversity,and 52 healthy donors were collected. MPs of the samples treated with different anticoagulants( sodium citrate,ethylenediaminetetraacetic acid-dipotassium[EDTA-K2],heparin),preparation methods( washed platelet-poor plasma[PPP],and directed PPP),storage temperatures(- 4 ℃,- 20 ℃,- 80 ℃),and times( 1,3,7,10,and 14 days) were detected with flowcytometer and compared. Results The content of MPs for the samples treated with sodium citrate plasma,EDTA-K2,heparin,and without anticoagulant were 1 527. 0 ± 620. 4,981. 4 ± 247. 9,877. 7 ± 176. 2,and 480. 8 ± 112. 2 μL,respectively,with significant differences( F = 9. 11,P〈0. 01). The MPs content of directed PPP samples from systemic lupus erythematosus patients,rheumatoid arthritis patients,and healthy donors were 1 972. 4 ± 2 850. 7,3 347. 8 ± 3 431. 5,and 2 157. 7 ± 1 901. 1 μL,respectively,and were all higher than those of washed PPP samples( 1 406. 4 ± 2 205. 7,2 375. 6 ± 2 500. 2,and 1 502. 8± 1 337. 1μL)( all P〈0. 01). Compared with those of the fresh plasma samples,the MPs content decreased significantly for the samples stored at the temperature of- 4 ℃,- 20 ℃,and- 80 ℃ and stored for 1,3,7,and 10 days( all P〈0. 05),but the content showed no significant difference when stored for 14 days at the temperature of- 4 ℃,- 20 ℃,and- 80 ℃( all P〉0. 05); there were also no significant differences in MPs content among the samples with various storage duration( 1- 14 days) at the three different temperatures( all P〉0. 05). Conclusion MPs content should be detected for fresh samples treated with EDTA-K2 and without of repeated washing and the storage temperature of- 4 ℃,- 20 ℃,and- 80 ℃ could selected for short time preservation of plasma sample.
出处 《中国公共卫生》 CAS CSCD 北大核心 2015年第3期356-358,共3页 Chinese Journal of Public Health
基金 国家自然科学基金(81202348) 江苏省自然科学基金(BK2012171) 江苏省高校自然科学研究项目(12KJD310006)
关键词 流式细胞术(FCM) 微粒(MPs) 抗凝剂 标本处理 保存 flowcytometry microparticles anticoagulant sample preparation preservation
  • 相关文献

参考文献13

  • 1Pisetsky DS, Gauley J, Ullal AJ. Microparticles as a source of ex- tracellular DNA [ J]. Immunologic Research, 2011,49 ( 1 - 3 ) : 227 - 234.
  • 2Reich CF,Pisetsky DS. The content of DNA and RNA in micropar- ticles released by Jurkat and HL-60 cells undergoing in vitro apop- tosis[ J].Experimental Cell Research,2009,315 (5) :760 - 768.
  • 3Ullal AJ, Reich CF, Clowse M, et al. Microparticles as antigenic targets of antibodies to DNA and nucleosomes in systemic lupus erythematosus[ J]. Journal of Autoimmunity, 2011,36 ( 3 - 4 ) : 173 - 180.
  • 4Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythema- tosus[ J]. Arthritis Rheum, 1997,40 : 1725.
  • 5Arnett FC, Edworthy SM, Bloch DA, et al. The American Rheu- matism Association 1987 revised criteria for the classification of rheumatoid arthritis [ J]. Arthritis Rheum, 1988,31:315 - 324.
  • 6Nielsen CT, Ostergaard O, Johnsen C, et al. Distinct features of circulating microparticles and their relationship to clinical mani- festations in systemic lupus erythematosus [ J ]. Arthritis and Rheumatism ,2011,63 (10) :3067 - 3077.
  • 7Sellam J,Proulle V,Jtmgel A,et al. Increased levels of circulating rrli- croparticles in primary Sjogren's syndrome,systemic lupus erythema- tosus and rheumatoid arthritis and relation with disease activity [ J]. Arthritis Research and Therapy ,2009,11 (5) :R156.
  • 8Iversen LV, φstergaard O, Nielsen CT, et al. A heparin-based method for flow cytornetric analysis of microparticles directly from platelet-poor plasma in calcium containing buffer[ J]. Jour- nal of Immunological Methods ,2013,388 ( 1 - 2) :49 - 59.
  • 9Dey-Hazra E, Hertel B, Kirsch T, et al. Detection of circulating microparticles by flow cytometry : influence of centrifugation, fil- tration of buffer, and freezing [ J]. Vascular Health and Risk Management,2010,6 : 1125 - 1133.
  • 10Nielsen CT, Ostergaard O, Stener L, et al. Increased IgG on cell- derived plasma microparticles in systemic lupus erythematosus is associated with autoantibodies and complement activation [ J ]. Arthritis and Rheumatism,2012,64(4) :1227 -1236.

二级参考文献11

  • 1WHO. World health report 2002[R].Gevana:WHO,2002.
  • 2王文.我国心血管病流行趋势与高血压防治效果分析.
  • 3宁光.2010年糖尿病.
  • 4陈竺.全国第三次死因回顾抽样调查报告[M]{H}北京:中国协和医科大学出版社,200858.
  • 5王宇.全国疾病监测系统死因监测数据集2010[M]{H}北京:军事医学科学出版社,201220.
  • 6World Health Organization. Global status report on noncommu nicable diseases 2010[R].{H}Geneva:World Health Organization,2011.
  • 7中国疾病预防控制中心慢性非传染性疾病预防控制中心.中国慢性病及其危险因素监测报告(2010)[M]{H}北京:军事医学科学出版社,2012.
  • 8Sihto M,Ollila E,Koivusalo M. Principles and challenges of health in all policies[A].Ministry of Social Affairs and Health and European Observatory on Health Systems and Policies,Helsinki,2006.3-20.
  • 9Ford ES,Ajani UA,Croft JC. Explaining the decrease in U.S.deaths from coronary disease,1980-2000[J].{H}New England Journal of Medicine,2007.2388-2398.
  • 10Napoli C,Crudele V,Soricelli A. Primary prevention of atherosclerosis A clinical challenge for the reversal of epigenetic mechanisms[J].{H}CIRCULATION,2012.2363-2373.

共引文献158

同被引文献81

引证文献7

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部